Plain-English translation of NCT07594262 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying the immune environment inside pituitary tumors — the cells and signals that surround and influence how tumors grow. By examining tissue samples from people having pituitary tumor surgery, this study aims to find new biological markers that could help doctors identify which tumors are more aggressive and predict how well treatments will work.
Currently, doctors don't have reliable ways to predict which pituitary tumors will be aggressive or how individual patients will respond to treatment. This research could unlock new therapeutic options, including immunotherapy approaches that help the body's own immune system fight the tumor.
You likely qualify if…
You likely don't qualify if…
If you qualify, your participation involves donating tumor tissue that is removed during your clinically necessary pituitary tumor surgery — this tissue would otherwise be discarded. Researchers will then analyze your tissue samples in the laboratory to study the immune environment and identify new biological markers. There are no additional procedures or visits required beyond your standard surgical care.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Italy